![United States: Going To 11: New Subsections At CDER's Office Of Pharmaceutical Quality Are Important Piece Of FDA's Inspection And Enforcement Strategy - Hyman, Phelps, & McNamara, P.C.](https://cdn.newsserve.net/ONPglobe256.png)
United States: Going To 11: New Subsections At CDER's Office Of Pharmaceutical Quality Are Important Piece Of FDA's Inspection And Enforcement Strategy - Hyman, Phelps, & McNamara, P.C.
The word last week was that FDA is re-organizing the Office of Pharmaceutical Quality (OPQ) within the Center for Drug Evaluation and Research (CDER).
Full Article